The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...

( NewsNation) — The director of medical weight management at West Virginia University says a canceled pilot program that provided weight-loss drugs to state employees showed “incredible” results, with ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Weight loss drugs like Ozempic and Wegovy have seemingly taken over this year, curbing users appetites by making them feel ...